Quin Wills Co-founder and CSO of Ochre Bio.

Quin is a medical doctor with further degrees in genetics, mathematics, computational biology, and a doctorate in systems genomics, from Oxford and Cambridge Universities. He started his first drug discovery liver genomics company 17 years ago. More recently he founded and led Novo Nordisk’s Advanced Genomics Department, again focused on liver disease. Frustrated with the lack of therapeutic innovation in chronic diseases, Quin co-founded Ochre Bio, a liver RNA therapeutics company with global R&D sites in Europe, Asia, and the US.